BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND HIST1H4I, MGC24116, 8294, P62805
8 results:

  • 1. Evaluation of physician performance using a concurrent-read artificial intelligence system to support breast ultrasound interpretation.
    Lai YC; Chen HH; Hsu JF; Hong YJ; Chiu TT; Chiou HJ
    Breast; 2022 Oct; 65():124-135. PubMed ID: 35944352
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive breast cancer.
    Braal CL; Jager A; Hoop EO; Westenberg JD; Lommen KMWT; de Bruijn P; Vastbinder MB; van Rossum-Schornagel QC; Thijs-Visser MF; van Alphen RJ; Struik LEM; Zuetenhorst HJM; Mathijssen RHJ; Koolen SLW
    Clin Pharmacokinet; 2022 Apr; 61(4):527-537. PubMed ID: 34786650
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis.
    Gao W; Zeng Y; Fei X; Chen X; Shen K
    Breast Cancer Res Treat; 2020 Nov; 184(1):193-202. PubMed ID: 32740809
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An accurate regression of developmental stages for breast cancer based on transcriptomic biomarkers.
    Feng X; Zhang R; Liu M; Liu Q; Li F; Yan Z; Zhou F
    Biomark Med; 2019 Jan; 13(1):5-15. PubMed ID: 30484698
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of the most significant magnetic resonance imaging (MRI) radiomic features in oncological patients with vertebral bone marrow metastatic disease: a feasibility study.
    Filograna L; Lenkowicz J; Cellini F; Dinapoli N; Manfrida S; Magarelli N; Leone A; Colosimo C; Valentini V
    Radiol Med; 2019 Jan; 124(1):50-57. PubMed ID: 30191445
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancer.
    Lozza L; Fariselli L; Sandri M; Rampa M; Pinzi V; De Santis MC; Franceschini M; Trecate G; Maugeri I; Fumagalli L; Bonfantini F; Bianchi G; Pignoli E; De Martin E; Agresti R
    Radiat Oncol; 2018 Mar; 13(1):49. PubMed ID: 29566762
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study.
    van Ramshorst MS; van Werkhoven E; Mandjes IAM; Schot M; Wesseling J; Vrancken Peeters MTFD; Meerum Terwogt JM; Bos MEM; Oosterkamp HM; Rodenhuis S; Linn SC; Sonke GS
    Eur J Cancer; 2017 Mar; 74():47-54. PubMed ID: 28335887
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expression.
    Waddell N; Ten Haaf A; Marsh A; Johnson J; Walker LC; ; Gongora M; Brown M; Grover P; Girolami M; Grimmond S; Chenevix-Trench G; Spurdle AB
    PLoS Genet; 2008 May; 4(5):e1000080. PubMed ID: 18497862
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.